David S. Block – Chairman and CEO
Henrik S. Olsen, Ph.D. – Vice President, Drug Discovery
Henrik Olsen was a founding employee at Human Genome Sciences where he worked for ten years. He worked at Artesian Therapeutics and then at Celera prior to joining Gliknik. A graduate of the University of Aarhus, Denmark, he completed his post-doctoral fellowship at the Roche Institute of Molecular Biology. Henrik is a named inventor on 62 issued U.S. patents. He oversees the Gliknik labs, including drug design, protein production and purification, analysis, and biologic testing.
Emmanuel Mérigeon, B.A., B.T.S. – Lab Manager
Lab manager Emmanuel Mérigeon received his Baccalauréat in Biochemistry in Orleans, France before receiving his Brevet de technicien supérieur en Biologie in Paris, France. Manu has worked in a variety of lab positions with increasing responsibility for more than two decades, including 10 years at Bio-Rad in France. Manu has day-to-day responsibility for protein production, purification, and analysis.
Jeffrey M. Herpst, R.N., B.S.N., O.C.N. – Senior Director, Clinical Development
Jeff Herpst has 20 years’ experience in clinical operations and an additional seven years as an oncology research nurse. He has held clinical development roles of increasing responsibility, most recently at Zyngenia, Teva, and Human Genome Sciences. Jeff received his BSN from the University of Maryland and worked initially at Johns Hopkins in the Division of Radiation Oncology.